Najat Khan
Direttore Tecnico/Scientifico/R&S presso RECURSION PHARMACEUTICALS, INC.
Profilo
Najat Khan is currently the Director, Chief Research & Development Officer at Recursion Pharmaceuticals, Inc. and a Director at Alliance For Artificial Intelligence In Healthcare.
They are also a Senior Advisor at General Atlantic LLC.
Previously, they held the position of Global Head of Strategy & Operations at Janssen Research & Development LLC and were a Member at The Boston Consulting Group.
Dr. Khan holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from Colgate University.
Posizioni attive di Najat Khan
| Società | Posizione | Inizio |
|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 16/04/2024 |
General Atlantic LLC
 General Atlantic LLC Investment ManagersFinance General Atlantic LLC (General Atlantic) is a private equity firm founded in 1980 by Charles F. Feeney. The firm is headquartered in New York. | Consulente / Consigliere | 13/12/2021 |
Alliance For Artificial Intelligence In Healthcare
 Alliance For Artificial Intelligence In Healthcare Packaged SoftwareTechnology Services The Alliance for Artificial Intelligence in Healthcare (AAIH) is an advocacy organization that aims to improve patient outcomes and minimize healthcare costs through the discovery, development, and delivery of better solutions. The private company is based in Long Island City, NY, and was founded by Brandon Allgood. The organization fosters creativity, collaboration, and knowledge sharing among its members, who come from diverse backgrounds in science, math, technology, and healthcare. AAIH is focusing on two primary practice areas in 2023: developing a comprehensive framework for digitizing IND and addressing core challenges in data accessibility through a real-world data registry. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Najat Khan
| Società | Posizione | Fine |
|---|---|---|
| The Boston Consulting Group | Corporate Officer/Principal | - |
Janssen Research & Development LLC
 Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Corporate Officer/Principal | - |
Formazione di Najat Khan
| Colgate University | Undergraduate Degree |
| University of Pennsylvania | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| RECURSION PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
General Atlantic LLC
General Atlantic LLC Investment ManagersFinance General Atlantic LLC (General Atlantic) is a private equity firm founded in 1980 by Charles F. Feeney. The firm is headquartered in New York. | Finance |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Commercial Services |
| The Boston Consulting Group | |
Alliance For Artificial Intelligence In Healthcare
Alliance For Artificial Intelligence In Healthcare Packaged SoftwareTechnology Services The Alliance for Artificial Intelligence in Healthcare (AAIH) is an advocacy organization that aims to improve patient outcomes and minimize healthcare costs through the discovery, development, and delivery of better solutions. The private company is based in Long Island City, NY, and was founded by Brandon Allgood. The organization fosters creativity, collaboration, and knowledge sharing among its members, who come from diverse backgrounds in science, math, technology, and healthcare. AAIH is focusing on two primary practice areas in 2023: developing a comprehensive framework for digitizing IND and addressing core challenges in data accessibility through a real-world data registry. | Technology Services |
- Borsa valori
- Insiders
- Najat Khan
